 |
Funding Opportunites - Research
Further details regarding this announcement can be found at:
http://www.cihr-irsc.gc.ca/e/34309.html
|
|
Sponsor/Award: |
CANADIAN INSTITUTE HEALTH RESEARCH - CATALYST GRANT - PREV/TREATMNT OF ILLICIT SUBSTANCE USE-2009 FALL COMPETITION |
|
|
Grant Amount: |
UPTO $100,000 FOR ONE YEAR |
|
Deadline: |
Dean's: Oct 19, 2009
Internal: Oct 26, 2009
Sponsor's: Nov 02, 2009
|
|
|
Subject Areas: |
Health Services Research, Drug Abuse Prevention, Feasibility Studies, Community Health, Drug Education, Drugs Of Abuse, Addiction, Substance Abuse Treatment, Social Impact, Economic Impact, illicit drugs, illicit drug use, drug dependencies |
|
Description: |
The CIHR Catalyst Grant program provides seed money, on a short-term basis, to support health research activities which represent a first step towards the pursuit of more comprehensive funding opportunities. The purpose of this Funding opportunity is to further strengthen state-of-the-science prevention and treatment of illicit drug by supporting crosscutting collaborative research.
The specific objectives of this funding opportunity are:
* To address scientific questions/problems related to the Treatment Action Plan of the New Anti-Drug Strategy.
* To improve the effectiveness of illicit drug use treatments and prevention strategies for highly vulnerable populations, such as youth and First Nations, M?tis and Inuit.
* To inform policy and program development in the area of illicit drug use prevention and treatment.
* To develop best practice guidelines for illicit drug use prevention and treatment.
* To address knowledge translation questions/problems related to prevention and treatment of illicit drug use.
Specific Research Foci and Requirements:
* The substances covered by this initiative are illicit drugs such as marijuana, cocaine, heroin, ecstasy and methamphetamine (crystal meth). Other psychoactive substances such as alcohol, psychotropic pharmaceuticals (over-the-counter and prescription), solvents and inhalants can be studied only if they are used in combination with an illicit drug. |
|
|
Application Details: |
Randomized Controlled Trials (RCTs) will not be considered through this program. For projects of a high risk nature, the potential for great scientific gain should offset the risk of failure. There should be minimal or no overlap with other funded work. Note: This funding opportunity requires the use of ResearchNet to apply for funding. The application process for this funding opportunity is comprised of two steps: Registration and Application.
Additional instructions that must be followed for this funding opportunity:
(Note: These additional instructions supersede all other policies or guidelines published by the Canadian Institutes of Health Research, including, but not limited to, the Grants and Awards Guide, the Memorandum of Understanding, etc.)
*The Research Proposal in the ?Enter Project Information and Supporting Documents? task under ?Project Information?, is limited to 8 pages.INDIRECT COSTS ARE NOT SUPPORTED BY THIS PROGRAM |
|
NOTE: Letters of Intent and Full Applications are to be processed through Research Development Services for institutional signatures, and are to be accompanied by a completed RDAF form (bearing applicant, Chair and Dean signatures). Requests for Institutional signatures should be received no less than 3 days prior to the posted Sponsor deadline. |
|
Western Contacts: |
Russelo,Theresa M
|
|
|
Sponsor Contacts: |
JOHANNE.LAPOINTE@CHIR-IRS.GC.CA
160 Elgin Street, 9th Floor
Address Locator 4809A
OTTAWA, Ontario, Canada
613 941-2672
|
|